No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Colorectal Neoplasms / drug therapy*
-
ErbB Receptors / antagonists & inhibitors
-
Humans
-
Oncogene Protein v-akt / antagonists & inhibitors
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Kinases / metabolism
-
Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors
-
Proto-Oncogene Proteins c-met / antagonists & inhibitors
-
Receptor, Platelet-Derived Growth Factor alpha / antagonists & inhibitors
-
Receptors, Somatomedin / antagonists & inhibitors
-
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
-
TNF-Related Apoptosis-Inducing Ligand / antagonists & inhibitors
-
TOR Serine-Threonine Kinases
-
src-Family Kinases / antagonists & inhibitors
Substances
-
Phosphoinositide-3 Kinase Inhibitors
-
Receptors, Somatomedin
-
TNF-Related Apoptosis-Inducing Ligand
-
MDM2 protein, human
-
Proto-Oncogene Proteins c-mdm2
-
Protein Kinases
-
MTOR protein, human
-
ErbB Receptors
-
Proto-Oncogene Proteins c-met
-
Receptor, Platelet-Derived Growth Factor alpha
-
Receptors, Vascular Endothelial Growth Factor
-
src-Family Kinases
-
Oncogene Protein v-akt
-
TOR Serine-Threonine Kinases